Palivizumab, CAS [[188039-54-5]]

Catalog Number: TGM-T76907
Article Name: Palivizumab, CAS [[188039-54-5]]
Biozol Catalog Number: TGM-T76907
Supplier Catalog Number: T76907
Alternative Catalog Number: TGM-T76907-1MG, TGM-T76907-5MG, TGM-T76907-10MG, TGM-T76907-25MG, TGM-T76907-50MG, TGM-T76907-100MG
Manufacturer: TargetMol
Category: Biochemikalien
Alternative Names: MEDI 493, Synagis
Palivizumab (MEDI 493) is a humanized RSV-specific monoclonal antibody that selectively inhibits epitopes at the F protein A antigenic site of RSV subtypes A and B for the prevention of respiratory syncytial virus infection (RSV).
CAS Number: [188039-54-5]
Target: RSV